Clinical pharmacist review
Every fill reviewed by a real PharmD against the patient's full regimen, comorbidities, and plan benefit. Not a fulfillment script.
QuantifyRx is a URAC-accredited specialty pharmacy. We dispense, yes — but the dispense is the start of the work, not the end of it. With our clinical operations behind every fill, we verify the therapy is the right one for the patient's actual condition and physiology. We send registered dietitians when food is fighting the drug. We send real nurses for real clinical interventions in the home — not a delivery-confirmation phone tree. We loop in behavioral health when staying on therapy is the hardest part. We don't just hand out medication; we make sure the medication actually improves the patient's health.
Where most specialty pharmacies are owned by PBMs, retail chains, or wholesalers, QuantifyRx is owned by a clinical organization whose only customer is the patient and the plan that pays for the care. That changes every incentive. We were founded by clinicians who watched too many patients on high-cost specialty therapies fall through the cracks of dispense-and-ship workflows — missed refills, temperature excursions, anaphylaxis events without a clinician at the other end of the phone, prior auths that died in someone's fax queue, side effects nobody noticed because no one was looking. QuantifyRx exists because that is not acceptable when the drug costs $200,000 a year and the patient's life depends on getting it right.
Real nursing interventions
Our RNs come to the home for first-fill, infusion supervision, anaphylaxis preparedness, and any clinical event. Not a tech, not a vendor.
Registered dietitian
For therapies where food — protein, dairy, leafy greens, alcohol, grapefruit — changes how the drug works, a dietitian is on the care plan from day one.
Behavioral health support
For patients struggling to stay on high-cost therapy — injection anxiety, depression, adherence fatigue — behavioral health is part of the team, not a referral.
URAC-accredited pharmacy
Accredited specialty pharmacy operations under URAC — the gold standard for specialty pharmacy accreditation. Accreditation ID MSP010001. Verify on URAC AccreditNet →
NHIA member
Active member of the National Home Infusion Association — the standard-setter for home and alternate-site infusion practice in the United States.
NCPA member
Active member of the National Community Pharmacists Association — the trade group representing more than 19,400 independent community pharmacies advocating for patient access and community-rooted pharmacy practice.
Anaphylaxis-trained, REMS-Plus operations
Anaphylaxis-trained RNs, standardized epinephrine kits, documented patient and caregiver education. The operating standard for every high-risk therapy — not a per-drug retrofit.
Meet the pharmacist leading QuantifyRx
Carl Black, PharmD
Chief Pharmacy Officer · QuantifyRx
Pharmacist-in-Charge at our URAC-accredited specialty pharmacy and a multi-state licensed PharmD covering 23+ states. Carl brings more than 15 years of mail-order specialty pharmacy operating experience, with deep expertise in front-end and back-end pharmacy workflow, State and Federal regulatory compliance, and inspection readiness. As Chief Pharmacy Officer he oversees all dispensing, REMS-Plus operations, clinical pharmacy practice, and the cold-chain workflow at our Fort Lauderdale facility — the pharmacist of record for our URAC accreditation and the named operational owner for every manufacturer relationship.
Before Quantify, Carl spent more than five years as Pharmacist-in-Charge at Optum, where he oversaw a high-volume mail-order pharmacy accountable for over 600 licensed pharmacists and technicians, served on the Pharmacy Practice Team setting companywide policy, and resolved 100% of State/Federal regulatory inquiries, inspections, and escalations. Earlier at Optum he led pharmacy supervision and verification, and before that spent nine years at ScriptPro training and supporting pharmacy automation at 400+ pharmacies nationwide — the kind of operator who understands the robotics and software under modern specialty fulfillment because he installed and serviced them.
He holds a Doctor of Pharmacy from the University of Kansas (concentration in Pharmacy Administration, Policy, and Regulatory Affairs) and is a U.S. Army Infantry veteran — Fort Benning, Georgia and Baumholder, Germany.
“Dispensing the drug is the easy part. Making sure it's the right drug, that the patient can take it, that the food they eat doesn't fight it, and that a nurse shows up when something changes — that's the part most of specialty pharmacy walked away from. We didn't.”
Clinical Advisory Board
A chair for every specialty. A peer-to-peer for every complex case.
Most specialty pharmacies dispense whatever the prescription says. We don't. Before high-cost or high-risk therapy goes out the door, the Quantify Clinical Advisory Board — a standing panel of board-certified physicians across oncology, neurology, gastroenterology, and rheumatology, paired with senior clinical nurses — reviews the case for medical appropriateness, evidence-based protocol fit, and patient safety. We don't just check whether the drug can be billed. We check whether it's the right treatment.
What the board reviews
- Complex oncology, autoimmune, rare-disease, and high-cost specialty cases
- Treatment protocols proposed by the prescribing physician — against current evidence and patient-specific factors
- Prior authorization decisions where the plan or PBM denial may be clinically wrong
- Drug-drug interactions, contraindications, and physiologic risk profiles
- Cases where a less invasive, equally effective therapy may be the better choice
Who sits on the board
- Alberto Montero, MD — Chair. Board-certified medical oncology.
- Specialty physician advisors across neurology, gastroenterology, and rheumatology
- Senior clinical RNs with infusion, oncology, and complex-care experience
- Carl Black, PharmD — Chief Pharmacy Officer, voting member on dispensing and REMS questions
- Liane Parker, RN, CPHM — Chief Clinical Operating Officer, ensures board decisions reach the bedside
A recent peer-to-peer clinical intervention
A patient was scheduled to start systemic chemotherapy. Dr. Montero reviewed the case in a direct peer-to-peer with the treating oncologist — pulling the pathology, the staging, and the recent imaging together — and identified that a less invasive, evidence-supported therapy was both safer for this patient's comorbidity profile and clinically superior given the actual tumor characteristics. The treatment plan was changed before the first cycle started. The patient avoided unnecessary toxicity, the plan avoided the cost of a wrong-protocol regimen, and the outcome was better — not because we dispensed faster, but because a physician actually looked at the chart and picked up the phone.
This is the difference between a pharmacy that ships and a pharmacy that practices.
Published remote-care results · Claris Healthcare case study, 2025
Continuous, clinician-led engagement — at scale.
In a published Claris Healthcare case study of our remote care program for a high-risk, underserved cohort, the clinical engagement looked like this over a single year:
180,000+total care activitiesacross the cohort in one year
100,000+care-team messagesbetween patients and their care staff
96,000+vital readings recordedacross 94% of members
100%alerts reviewed & closedevery monitoring alert worked to resolution
86%medication reminders completedadherence above industry averages
98%members active on calendarsustained engagement, not enrollment-only